A new report from the American Society of Plastic Surgeons reveals year-over-year increases in both surgical and nonsurgical aesthetic procedures in 2024.
Despite economic headwinds in 2024, overall patient demand for plastic surgery procedures remained steady, the American Society of Plastic Surgeons (ASPS) revealed in its latest annual report.
The 2024 ASPS Procedural Statistics Report found that the total number of cosmetic surgeries and minimally invasive treatments remained stable in 2024, showing respective 1% and 3% year-over-year increases.
“Patients continued to prioritize their aesthetic health in 2024 despite the unpredictable economic uncertainty they faced throughout the year, with growth across plastic surgical procedures, minimally invasive treatments, and reconstructive surgery,” says ASPS president Scott Hollenbeck, MD, in a release. “People want to look and feel their best so they can face the challenges of everyday life with greater confidence. However, amid ongoing economic uncertainty, safety must remain the top priority. We strongly recommend that patients consult ASPS Member Surgeons for any cosmetic or reconstructive procedure to ensure the highest standard of care.”
Most Popular Procedures
Of the nearly 1.6 million cosmetic surgical procedures performed in 2024, the top five were:
- Liposuction: 349,728 procedures
- Breast augmentation: 306,196 procedures
- Tummy tuck (abdominoplasty): 171,064 procedures
- Breast lift: 153,616 procedures
- Eyelid surgery (blepharoplasty): 120,755 procedures
Of the over 28.5 million minimally invasive procedures in 2024, the top five were:
- Neuromodulator injections: 9,883,711 procedures
- Hyaluronic acid (HA) fillers: 5,331,426 procedures
- Skin resurfacing (eg, dermabrasion, chemical peel, ablative/non-ablative laser, microdermabrasion): 3,703,305 procedures
- Skin treatment (eg, laser hair removal, IPL treatment, laser tattoo removal, laser treatment of leg veins): 3,112,056 procedures
- Lip augmentation (with injectable materials): 1,449,565 procedures
Of the more than 1 million reconstructive procedures performed in 2024, the top five were:
- Tumor removal (including skin cancer): 361,798 procedures
- Hand surgery (ie, carpal tunnel, arthritis, trigger finger): 208,480 procedures
- Breast reconstruction: 162,579 procedures
- Maxillofacial surgery: 54,747 procedures
- Scar Revision: 54,280 procedures
Lifts, Tucks, and Weight Loss
Plastic surgeons are playing an increasingly crucial role in many patients’ weight loss journeys, bringing both medical expertise and years of experience in helping individuals restore their physical health. For the first time, the 2024 ASPS Procedural Statistics Report has measured the prescription of weight loss medications by its members, with over 800,000 aesthetic patients utilizing them to support their health goals in 2024.
The report found 20% of GLP-1 patients under the care of ASPS member surgeons have already undergone plastic surgery, while 39% are considering a surgical procedure, and 41% are considering a nonsurgical procedure. While not a substitute for weight loss surgery, body contouring procedures can help GLP-1 patients achieve balance, improved functionality, and enhanced self-esteem. It is important to consult a board-certified plastic surgeon to safely navigate the plastic surgery and weight loss journey.
Tummy tucks remained the second most popular procedure, with a 1% increase from 2023. Facelifts and forehead lifts both grew by 1% as well. Buttock and thigh lifts rose by 3%, upper arm lifts grew by 2%, and neck lifts climbed by 2%.
Injectables on the Rise
Likely due to their affordability and short recovery times, minimally invasive injectable treatments grew 3% in 2024, well over the 1% increase that surgical cosmetic procedures saw.
Injectables, known for their personalization and subtle results, remained a clear favorite. Neuromodulators such as Botox saw a 4% year-over-year increase, maintaining their spot as the top minimally invasive treatment, while hyaluronic acid (HA) fillers grew by 1%. Demand for lip and non-HA fillers remained consistently strong.
ID 385552091 | Patient © Lacheev | Dreamstime.com
